https://www.news-medical.net/news/20090802/FDA-approves-Onglyza-(saxagliptin)-for-type-2-diabetes.aspx
FDA approves Onglyza (saxagliptin) for type 2 diabetes
Jun 24, 2019 - The U.S. Food and Drug Administration has approved Onglyza (saxagliptin), a once-daily tablet to treat Type 2 diabetes in adults. The medication is intended to...
fda approvesonglyzasaxagliptintypediabetes
https://pubchem.ncbi.nlm.nih.gov/compound/Metformin-hydrochloride_-saxagliptin_-dapagliflozin
Metformin hydrochloride, saxagliptin, dapagliflozin - PubChem
Metformin hydrochloride, saxagliptin, dapagliflozin chemical information summary.
metformin hydrochloridesaxagliptindapagliflozinpubchem
https://adisinsight.springer.com/trials/700196501?error=cookies_not_supported&code=b78f7b7e-c060-4c20-9ad9-ff6fe39e2f66
Effects of Saxagliptin on Endothelial Function in Patients With Type 2 Diabetes. - AdisInsight
This trial investigated the efficacy of saxagliptin [Onglyza] on endothelial and vascular function of retinal circulation in patients with
https://adisinsight.springer.com/patents/800038479
Dapagliflozin/saxagliptin - AstraZeneca - AdisInsight
dapagliflozinsaxagliptinastrazenecaadisinsight